Super-enhancers: drivers of cells’ identities and cells’ debacles

Papers of special note have been highlighted as: •• of considerable interest

References

• 1. Banerji J, Rusconi S, Schaffner W. Expression of a beta-globin gene is enhanced by remote SV40 DNA sequences. Cell 27(2 Pt 1), 299–308 (1981).
  Medline CASGoogle Scholar
• 2. Schaffner W. Enhancers, enhancers – from their discovery to today’s universe of transcription enhancers. Biol. Chem. 396(4), 311–327 (2015).
  Medline CASGoogle Scholar
• 3. Mercola M, Wang XF, Olsen J, Calame K. Transcriptional enhancer elements in the mouse immunoglobulin heavy chain locus. Science 221(4611), 663–665 (1983).
  Medline CASGoogle Scholar
• 4. Banerji J, Olson L, Schaffner W. A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes. Cell 33(3), 729–740 (1983).
  Medline CASGoogle Scholar
• 5. Gillies SD, Morrison SL, Oi VT, Tonegawa S. A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene. Cell 33(3), 717–728 (1983).
  Medline CASGoogle Scholar
• 6. Bogdanovic O, Fernandez-Miñán A, Tena JJ et al. Dynamics of enhancer chromatin signatures mark the transition from pluripotency to cell specification during embryogenesis. Genome Res. 22(10), 2043–2053 (2012).
  Medline CASGoogle Scholar
• 7. Bonn S, Zinzen RP, Girardot C et al. Tissue-specific analysis of chromatin state identifies temporal signatures of enhancer activity during embryonic development. Nat. Genet. 44(2), 148–156 (2012).
  Medline CASGoogle Scholar
• 8. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489(7414), 57–74 (2012).
  MedlineGoogle Scholar
• 9. Whyte WA, Orlando DA, Hnisz D et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153(2), 307–319 (2013).
  Medline CASGoogle Scholar
• 10. Hnisz D, Abraham BJ, Lee TI et al. Super-enhancers in the control of cell identity and disease. Cell 155(4), 934–947 (2013).
  Medline CASGoogle Scholar
• 11. Lovén J, Hoke HA, Lin CY et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 153(2), 320–334 (2013).
  Medline CASGoogle Scholar
• 12. Panigrahi A, O'Malley BW. Mechanisms of enhancer action: the known and the unknown. Genome Biol. 22(1), 108 (2021).
  Medline CASGoogle Scholar
• 13. Oudelaar AM, Higgs DR. The relationship between genome structure and function. Nat. Rev. Genet. 22(3), 154–168 (2021).
  Medline CASGoogle Scholar
• 14. Kang Y, Kang J, Kim A. Histone H3K4me1 strongly activates the DNase I hypersensitive sites in super-enhancers than those in typical enhancers. Biosci. Rep. 41(7), BSR20210691 (2021).
  Medline CASGoogle Scholar
• 15. Lee B-K, Jang YJ, Kim M et al. Super-enhancer-guided mapping of regulatory networks controlling mouse trophoblast stem cells. Nat. Commun. 10(1), 4749 (2019).
  MedlineGoogle Scholar
• 16. Sanchez R, Zhou M-M. The role of human bromodomains in chromatin biology and gene transcription. Curr. Opin. Drug Discov. Devel. 12(5), 659–665 (2009).
  Medline CASGoogle Scholar
• 17. Shi J, Vakoc CR. The mechanisms behind the therapeutic activity of BET bromodomain inhibition. Mol. Cell 54(5), 728–736 (2014).
  Medline CASGoogle Scholar
• 18. Lee J-E, Park Y-K, Park S et al. Brd4 binds to active enhancers to control cell identity gene induction in adipogenesis and myogenesis. Nat. Commun. 8(1), 2217 (2017).
  MedlineGoogle Scholar
• 19. Dong J, Li J, Li Y, Ma Z, Yu Y, Wang C-Y. Transcriptional super-enhancers control cancer stemness and metastasis genes in squamous cell carcinoma. Nat. Commun. 12(1), 3974 (2021).
  Medline CASGoogle Scholar
• 20. Jang MK, Mochizuki K, Zhou M, Jeong H-S, Brady JN, Ozato K. The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Mol. Cell 19(4), 523–534 (2005).
  Medline CASGoogle Scholar
• 21. Esnault C, Ghavi-Helm Y, Brun S et al. Mediator-dependent recruitment of TFIIH modules in preinitiation complex. Mol. Cell 31(3), 337–346 (2008).
  Medline CASGoogle Scholar
• 22. Compe E, Egly J-M. TFIIH: when transcription met DNA repair. Nat. Rev. Mol. Cell Biol. 13(6), 343–354 (2012).
  Medline CASGoogle Scholar
• 23. Yang Z, Yik JHN, Chen R et al. Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. Mol. Cell 19(4), 535–545 (2005).
  Medline CASGoogle Scholar
• 24. Marshall NF, Peng J, Xie Z, Price DH. Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase. J. Biol. Chem. 271(43), 27176–27183 (1996).
  Medline CASGoogle Scholar
• 25. Peterlin BM, Price DH. Controlling the elongation phase of transcription with P-TEFb. Mol. Cell 23(3), 297–305 (2006).
  Medline CASGoogle Scholar
• 26. Harlen KM, Churchman LS. The code and beyond: transcription regulation by the RNA polymerase II carboxy-terminal domain. Nat. Rev. Mol. Cell Biol. 18(4), 263–273 (2017).
  Medline CASGoogle Scholar
• 27. Chipumuro E, Marco E, Christensen CL et al. CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer. Cell 159(5), 1126–1139 (2014).
  Medline CASGoogle Scholar
• 28. Jia Q, Chen S, Tan Y, Li Y, Tang F. Oncogenic super-enhancer formation in tumorigenesis and its molecular mechanisms. Exp. Mol. Med. 52(5), 713–723 (2020).
  Medline CASGoogle Scholar
• 29. Dancy BM, Cole PA. Protein lysine acetylation by p300/CBP. Chem. Rev. 115(6), 2419–2452 (2015).
  Medline CASGoogle Scholar
• 30. Buenrostro J, Wu B, Chang H, Greenleaf W. ATAC-seq: a method for assaying chromatin accessibility genome-wide. Curr. Protoc. Mol. Biol. 109, 21.29.1–21.29.9 (2015).
  MedlineGoogle Scholar
• 31. De Santa F, Barozzi I, Mietton F et al. A large fraction of extragenic RNA pol II transcription sites overlap enhancers. PLOS Biol. 8(5), e1000384 (2010).
  MedlineGoogle Scholar
• 32. Kim T-K, Hemberg M, Gray JM et al. Widespread transcription at neuronal activity-regulated enhancers. Nature 465(7295), 182–187 (2010).
  Medline CASGoogle Scholar
• 33. Sartorelli V, Lauberth SM. Enhancer RNAs are an important regulatory layer of the epigenome. Nat. Struct. Mol. Biol. 27(6), 521–528 (2020).
  Medline CASGoogle Scholar
• 34. Ye R, Cao C, Xue Y. Enhancer RNA: biogenesis, function, and regulation. Essays Biochem. 64(6), 883–894 (2020).
  Medline CASGoogle Scholar
• 35. Andersson R, Gebhard C, Miguel-Escalada I et al. An atlas of active enhancers across human cell types and tissues. Nature 507(7493), 455–461 (2014).
  Medline CASGoogle Scholar
• 36. Li W, Notani D, Ma Q et al. Functional importance of eRNAs for estrogen-dependent transcriptional activation events. Nature 498(7455), 516–520 (2013).
  Medline CASGoogle Scholar
• 37. Bose DA, Donahue G, Reinberg D, Shiekhattar R, Bonasio R, Berger SL. RNA binding to CBP stimulates histone acetylation and transcription. Cell 168(1–2), 135–149.e22 (2017).
  Medline CASGoogle Scholar
• 38. Sigova AA, Abraham BJ, Ji X et al. Transcription factor trapping by RNA in gene regulatory elements. Science 350(6263), 978–981 (2015).
  Medline CASGoogle Scholar
• 39. Schaukowitch K, Joo J-Y, Liu X, Watts JK, Martinez C, Kim T-K. Enhancer RNA facilitates NELF release from immediate early genes. Mol. Cell 56(1), 29–42 (2014).
  Medline CASGoogle Scholar
• 40. Zhao Y, Wang L, Ren S et al. Activation of P-TEFb by androgen receptor-regulated enhancer RNAs in castration-resistant prostate cancer. Cell Rep. 15(3), 599–610 (2016).
  Medline CASGoogle Scholar
• 41. Pefanis E, Wang J, Rothschild G et al. RNA exosome regulated long non-coding RNA transcription controls super-enhancer activity. Cell 161(4), 774–789 (2015).
  Medline CASGoogle Scholar
• 42. Esnault C, Magat T, García-Oliver E, Andrau J-C. Analyses of promoter, enhancer, and nucleosome organization in mammalian cells by MNase-seq. Methods Mol. Biol. 2351, 93–104 (2021).
  Medline CASGoogle Scholar
• 43. West JA, Cook A, Alver BH et al. Nucleosomal occupancy changes locally over key regulatory regions during cell differentiation and reprogramming. Nat. Commun. 5, 4719 (2014).
  Medline CASGoogle Scholar
• 44. Sudhakar SRN, Wu L, Patel S, Zovoilis A, Davie JR. Histone H4 asymmetrically dimethylated at arginine 3 (H4R3me2a), a mark of super-enhancers. Biochem. Cell Biol. (2023).
  Google Scholar
• 45. Das ND, Chang J-C, Hon C-C et al. Defining super-enhancers by highly ranked histone H4 multi-acetylation levels identifies transcription factors associated with glioblastoma stem-like properties. BMC Genomics 24(1), 574 (2023).
  Medline CASGoogle Scholar
• 46. Narita T, Higashijima Y, Kilic S, Maskey E, Neumann K, Choudhary C. The logic of native enhancer–promoter compatibility and cell-type-specific gene expression variation. bioRxiv. doi:2022.07.18.500456 (2022) (Epub ahead of print). www.biorxiv.org/content/10.1101/2022.07.18.500456v2
  Google Scholar
• 47. Narita T, Higashijima Y, Kilic S, Liebner T, Walter J, Choudhary C. Acetylation of histone H2B marks active enhancers and predicts CBP/p300 target genes. Nat. Genet. 55(4), 679–692 (2023).
  Medline CASGoogle Scholar
• 48. Zhang T, Zhang Z, Dong Q, Xiong J, Zhu B. Histone H3K27 acetylation is dispensable for enhancer activity in mouse embryonic stem cells. Genome Biol. 21(1), 45 (2020).
  Medline CASGoogle Scholar
• 49. Sankar A, Mohammad F, Sundaramurthy AK et al. Histone editing elucidates the functional roles of H3K27 methylation and acetylation in mammals. Nat. Genet. 54(6), 754–760 (2022).
  Medline CASGoogle Scholar
• 50. Rickels R, Herz H-M, Sze CC et al. Histone H3K4 monomethylation catalyzed by Trr and mammalian COMPASS-like proteins at enhancers is dispensable for development and viability. Nat. Genet. 49(11), 1647–1653 (2017).
  Medline CASGoogle Scholar
• 51. Boileau RM, Chen KX, Blelloch R. Loss of MLL3/4 decouples enhancer H3K4 monomethylation, H3K27 acetylation, and gene activation during embryonic stem cell differentiation. Genome Biol. 24(1), 41 (2023).
  Medline CASGoogle Scholar
• 52. Calo E, Wysocka J. Modification of enhancer chromatin: what, how, and why? Mol. Cell 49(5), 825–837 (2013).
  Medline CASGoogle Scholar
• 53. Ko JY, Oh S, Yoo K. Functional enhancers as master regulators of tissue-specific gene regulation and cancer development. Mol. Cells 40(3), 169–177 (2017).
  Medline CASGoogle Scholar
• 54. Ernst J, Kheradpour P, Mikkelsen TS et al. Systematic analysis of chromatin state dynamics in nine human cell types. Nature 473(7345), 43–49 (2011).
  Medline CASGoogle Scholar
• 55. Heintzman ND, Stuart RK, Hon G et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 39(3), 311–318 (2007).
  Medline CASGoogle Scholar
• 56. Niu C, Wang S, Guo J et al. BACH1 recruits NANOG and histone H3 lysine 4 methyltransferase MLL/SET1 complexes to regulate enhancer–promoter activity and maintains pluripotency. Nucleic Acids Res. 49(4), 1972–1986 (2021).
  Medline CASGoogle Scholar
• 57. Kempfer R, Pombo A. Methods for mapping 3D chromosome architecture. Nat. Rev. Genet. 21(4), 207–226 (2020).
  Medline CASGoogle Scholar
• 58. Pongubala JMR, Murre C. Spatial organization of chromatin: transcriptional control of adaptive immune cell development. Front. Immunol. 12, 633825 (2021).
  Medline CASGoogle Scholar
• 59. Galganski L, Urbanek MO, Krzyzosiak WJ. Nuclear speckles: molecular organization, biological function and role in disease. Nucleic Acids Res. 45(18), 10350–10368 (2017).
  Medline CASGoogle Scholar
• 60. Dixon JR, Jung I, Selvaraj S et al. Chromatin architecture reorganization during stem cell differentiation. Nature 518(7539), 331–336 (2015).
  Medline CASGoogle Scholar
• 61. Zheng H, Xie W. The role of 3D genome organization in development and cell differentiation. Nat. Rev. Mol. Cell Biol. 20(9), 535–550 (2019).
  Medline CASGoogle Scholar
• 62. Fudenberg G, Imakaev M, Lu C, Goloborodko A, Abdennur N, Mirny LA. Formation of chromosomal domains by loop extrusion. Cell Rep. 15(9), 2038–2049 (2016).
  Medline CASGoogle Scholar
• 63. Szabo Q, Bantignies F, Cavalli G. Principles of genome folding into topologically associating domains. Sci. Adv. 5(4), eaaw1668 (2019).
  Medline CASGoogle Scholar
• 64. Symmons O, Uslu VV, Tsujimura T et al. Functional and topological characteristics of mammalian regulatory domains. Genome Res. 24(3), 390–400 (2014).
  Medline CASGoogle Scholar
• 65. Bonev B, Mendelson Cohen N, Szabo Q et al. Multiscale 3D genome rewiring during mouse neural development. Cell 171(3), 557–572.e24 (2017).
  Medline CASGoogle Scholar
• 66. Nora EP, Lajoie BR, Schulz EG et al. Spatial partitioning of the regulatory landscape of the X-inactivation centre. Nature 485(7398), 381–385 (2012).
  Medline CASGoogle Scholar
• 67. Zhan Y, Mariani L, Barozzi I et al. Reciprocal insulation analysis of Hi-C data shows that TADs represent a functionally but not structurally privileged scale in the hierarchical folding of chromosomes. Genome Res. 27(3), 479–490 (2017).
  Medline CASGoogle Scholar
• 68. Gong Y, Lazaris C, Sakellaropoulos T et al. Stratification of TAD boundaries reveals preferential insulation of super-enhancers by strong boundaries. Nat. Commun. 9(1), 542 (2018).
  MedlineGoogle Scholar
• 69. Rao SSP, Huntley MH, Durand NC et al. A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell 159(7), 1665–1680 (2014).
  Medline CASGoogle Scholar
• 70. Ea V, Baudement M-O, Lesne A, Forné T. Contribution of topological domains and loop formation to 3D chromatin organization. Genes 6(3), 734–750 (2015).
  Medline CASGoogle Scholar
• 71. Lawson HA, Liang Y, Wang T. Transposable elements in mammalian chromatin organization. Nat. Rev. Genet. 24(10), 712–723 (2023).
  Medline CASGoogle Scholar
• 72. Schmitt AD, Hu M, Jung I et al. A compendium of chromatin contact maps reveals spatially active regions in the human genome. Cell Rep. 17(8), 2042–2059 (2016).
  Medline CASGoogle Scholar
• 73. Di Giammartino DC, Kloetgen A, Polyzos A et al. KLF4 is involved in the organization and regulation of pluripotency-associated three-dimensional enhancer networks. Nat. Cell Biol. 21(10), 1179–1190 (2019).
  MedlineGoogle Scholar
• 74. Huang J, Li K, Cai W et al. Dissecting super-enhancer hierarchy based on chromatin interactions. Nat. Commun. 9(1), 943 (2018).
  MedlineGoogle Scholar
• 75. Lai F, Orom UA, Cesaroni M et al. Activating RNAs associate with Mediator to enhance chromatin architecture and transcription. Nature 494(7438), 497–501 (2013).
  Medline CASGoogle Scholar
• 76. Narendra V, Bulajić M, Dekker J, Mazzoni EO, Reinberg D. CTCF-mediated topological boundaries during development foster appropriate gene regulation. Genes Dev. 30(24), 2657–2662 (2016).
  Medline CASGoogle Scholar
• 77. Müller H-P, Sogo J, Schaffner W. An enhancer stimulates transcription in trans when attached to the promoter via a protein bridge. Cell 58(4), 767–777 (1989).
  Medline CASGoogle Scholar
• 78. Bateman JR, Johnson JE, Locke MN. Comparing enhancer action in cis and in trans. Genetics 191(4), 1143–1155 (2012).
  Medline CASGoogle Scholar
• 79. Mattioli K, Oliveros W, Gerhardinger C et al. Cis and trans effects differentially contribute to the evolution of promoters and enhancers. Genome Biol. 21(1), 210 (2020).
  Medline CASGoogle Scholar
• 80. Lajoie BR, Dekker J, Kaplan N. The hitchhiker’s guide to Hi-C analysis: practical guidelines. Methods 72, 65–75 (2015).
  Medline CASGoogle Scholar
• 81. Mitra S, Malik R, Wong W et al. Single-cell multi-ome regression models identify functional and disease-associated enhancers and enable chromatin potential analysis. Nat Genet. doi: 10.1038/s41588-024-01689-8 (2024).
  MedlineGoogle Scholar
• 82. Joffe B, Leonhardt H, Solovei I. Differentiation and large scale spatial organization of the genome. Curr. Opin. Genet. Dev. 20(5), 562–569 (2010).
  Medline CASGoogle Scholar
• 83. Williamson I, Berlivet S, Eskeland R et al. Spatial genome organization: contrasting views from chromosome conformation capture and fluorescence in situ hybridization. Genes Dev. 28(24), 2778–2791 (2014).
  MedlineGoogle Scholar
• 84. Kwon S, Chin K, Nederlof M, Gray JW. Quantitative, in situ analysis of mRNAs and proteins with subcellular resolution. Sci. Rep. 7(1), 16459 (2017).
  MedlineGoogle Scholar
• 85. Du M, Stitzinger SH, Spille J-H et al. Direct observation of a condensate effect on super-enhancer controlled gene bursting. Cell 187(2), 331–344.e17 (2024).
  Medline CASGoogle Scholar
• 86. Boettiger A, Murphy S. Advances in chromatin imaging at kilobase-scale resolution. Trends Genet. 36(4), 273–287 (2020).
  Medline CASGoogle Scholar
• 87. Su J-H, Zheng P, Kinrot SS, Bintu B, Zhuang X. Genome-scale imaging of the 3D organization and transcriptional activity of chromatin. Cell 182(6), 1641–1659.e26 (2020).
  Medline CASGoogle Scholar
• 88. Hay D, Hughes JR, Babbs C et al. Genetic dissection of the α-globin super-enhancer in vivo. Nat. Genet. 48(8), 895–903 (2016).
  Medline CASGoogle Scholar
• 89. Shin HY, Willi M, HyunYoo K et al. Hierarchy within the mammary STAT5-driven Wap super-enhancer. Nat. Genet. 48(8), 904–911 (2016).
  Medline CASGoogle Scholar
• 90. Moorthy SD, Davidson S, Shchuka VM et al. Enhancers and super-enhancers have an equivalent regulatory role in embryonic stem cells through regulation of single or multiple genes. Genome Res. 27(2), 246–258 (2017).
  Medline CASGoogle Scholar
• 91. Stine ZE, McGaughey DM, Bessling SL, Li S, McCallion AS. Steroid hormone modulation of RET through two estrogen responsive enhancers in breast cancer. Hum. Mol. Genet. 20(19), 3746–3756 (2011).
  Medline CASGoogle Scholar
• 92. Guerrero L, Marco-Ferreres R, Serrano AL, Arredondo JJ, Cervera M. Secondary enhancers synergise with primary enhancers to guarantee fine-tuned muscle gene expression. Dev. Biol. 337(1), 16–28 (2010).
  Medline CASGoogle Scholar
• 93. Blayney JW, Francis H, Rampasekova A et al. Super-enhancers include classical enhancers and facilitators to fully activate gene expression. Cell 186(26), 5826–5839.e18 (2023).
  Medline CASGoogle Scholar
• 94. Lambert SA, Jolma A, Campitelli LF et al. The human transcription factors. Cell 172(4), 650–665 (2018).
  Medline CASGoogle Scholar
• 95. Liu J, Perumal NB, Oldfield CJ, Su EW, Uversky VN, Dunker AK. Intrinsic disorder in transcription factors. Biochemistry 45(22), 6873–6888 (2006).
  Medline CASGoogle Scholar
• 96. Palacio M, Taatjes DJ. Merging established mechanisms with new insights: condensates, hubs, and the regulation of RNA polymerase II transcription. J. Mol. Biol. 434(1), 167216 (2022).
  Medline CASGoogle Scholar
• 97. Xie H, Vucetic S, Iakoucheva LM et al. Functional anthology of intrinsic disorder. I. Biological processes and functions of proteins with long disordered regions. J. Proteome Res. 6(5), 1882–1898 (2007).
  Medline CASGoogle Scholar
• 98. Wang B, Zhang L, Dai T et al. Liquid–liquid phase separation in human health and diseases. Signal Transduct. Target. Ther. 6(1), 1–16 (2021).
  MedlineGoogle Scholar
• 99. Vicioso-Mantis M, Fueyo R, Navarro C et al. JMJD3 intrinsically disordered region links the 3D-genome structure to TGFβ-dependent transcription activation. Nat. Commun. 13(1), 3263 (2022).
  Medline CASGoogle Scholar
• 100. Sabari BR, Dall’Agnese A, Boija A et al. Coactivator condensation at super-enhancers links phase separation and gene control. Science 361(6400), eaar3958 (2018). •• One of the first publications highlighting and describing the creation of protranscriptional macromolecular condensates at super-enhancer/target gene loci, propelling the expression of super-enhancers’ targets.
  MedlineGoogle Scholar
• 101. Cho W-K, Jayanth N, English BP et al. RNA polymerase II cluster dynamics predict mRNA output in living cells. Elife 5, e13617 (2016).
  MedlineGoogle Scholar
• 102. Hnisz D, Shrinivas K, Young RA, Chakraborty AK, Sharp PA. A phase separation model predicts key features of transcriptional control. Cell 169(1), 13–23 (2017). •• One of the first publications highlighting and describing the creation of protranscriptional macromolecular condensates at super-enhancer/target gene loci, propelling the expression of super-enhancers’ targets.
  Medline CASGoogle Scholar
• 103. Boija A, Klein IA, Sabari BR et al. Transcription factors activate genes through the phase-separation capacity of their activation domains. Cell 175(7), 1842–1855.e16 (2018). •• One of the first publications highlighting and describing the creation of protranscriptional macromolecular condensates at super-enhancer/target gene loci, propelling the expression of super-enhancers’ targets.
  Medline CASGoogle Scholar
• 104. Sabari BR, Dall'Agnese A, Young RA. Biomolecular condensates in the nucleus. Trends Biochem. Sci. 45(11), 961–977 (2020).
  Medline CASGoogle Scholar
• 105. Hnisz D, Schuijers J, Lin CY et al. Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers. Mol. Cell 58(2), 362–370 (2015).
  Medline CASGoogle Scholar
• 106. Bader M. Tissue renin–angiotensin–aldosterone systems: targets for pharmacological therapy. Annu. Rev. Pharmacol. Toxicol. 50, 439–465 (2010).
  Medline CASGoogle Scholar
• 107. Sequeira López MLS, Pentz ES, Nomasa T, Smithies O, Gomez RA. Renin cells are precursors for multiple cell types that switch to the renin phenotype when homeostasis is threatened. Dev. Cell 6(5), 719–728 (2004).
  MedlineGoogle Scholar
• 108. Martinez MF, Medrano S, Brown RI et al. Super-enhancers maintain renin-expressing cell identity and memory to preserve multi-system homeostasis. J. Clin. Invest. 128(11), 4787–4803 (2018).
  MedlineGoogle Scholar
• 109. Sakaguchi S. Naturally arising CD4⁺ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22, 531–562 (2004).
  Medline CASGoogle Scholar
• 110. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299(5609), 1057–1061 (2003).
  Medline CASGoogle Scholar
• 111. Lio C-WJ, Hsieh C-S. A two-step process for thymic regulatory T cell development. Immunity 28(1), 100–111 (2008).
  Medline CASGoogle Scholar
• 112. Toker A, Engelbert D, Garg G et al. Active demethylation of the Foxp3 locus leads to the generation of stable regulatory T cells within the thymus. J. Immunol. 190(7), 3180–3188 (2013).
  Medline CASGoogle Scholar
• 113. Kitagawa Y, Ohkura N, Kidani Y et al. Guidance of regulatory T cell development by Satb1-dependent super-enhancer establishment. Nat. Immunol. 18(2), 173–183 (2017).
  Medline CASGoogle Scholar
• 114. Ma S, Meng Z, Chen R, Guan K-L. The Hippo pathway: biology and pathophysiology. Annu. Rev. Biochem. 88(1), 577–604 (2019).
  Medline CASGoogle Scholar
• 115. Sun X, Ren Z, Cun Y et al. Hippo-YAP signaling controls lineage differentiation of mouse embryonic stem cells through modulating the formation of super-enhancers. Nucleic Acids Res. 48(13), 7182–7196 (2020).
  Medline CASGoogle Scholar
• 116. Yu W, Chen K, Ye G et al. SNP-adjacent super enhancer network mediates enhanced osteogenic differentiation of MSCs in ankylosing spondylitis. Hum. Mol. Genet. 30(3–4), 277–293 (2021).
  Medline CASGoogle Scholar
• 117. Zhu W, He X, Cheng K et al. Ankylosing spondylitis: etiology, pathogenesis, and treatments. Bone Res. 7, 22 (2019).
  MedlineGoogle Scholar
• 118. Xie Z, Wang P, Li Y et al. Imbalance between bone morphogenetic protein 2 and noggin induces abnormal osteogenic differentiation of mesenchymal stem cells in ankylosing spondylitis. Arthritis Rheumatol. 68(2), 430–440 (2016).
  Medline CASGoogle Scholar
• 119. Corradin O, Saiakhova A, Akhtar-Zaidi B et al. Combinatorial effects of multiple enhancer variants in linkage disequilibrium dictate levels of gene expression to confer susceptibility to common traits. Genome Res. 24(1), 1–13 (2014).
  Medline CASGoogle Scholar
• 120. Yamagata K, Nakayamada S, Tanaka Y. Critical roles of super-enhancers in the pathogenesis of autoimmune diseases. Inflamm. Regen. 40, 16 (2020).
  Medline CASGoogle Scholar
• 121. Jiang Y, Qian F, Bai X et al. SEdb: a comprehensive human super-enhancer database. Nucleic Acids Res. 47(D1), D235–D243 (2019).
  Medline CASGoogle Scholar
• 122. Bates GP, Dorsey R, Gusella JF et al. Huntington disease. Nat. Rev. Dis. Primers 1(1), 1–21 (2015).
  Google Scholar
• 123. Achour M, Le Gras S, Keime C et al. Neuronal identity genes regulated by super-enhancers are preferentially down-regulated in the striatum of Huntington’s disease mice. Hum. Mol. Genet. 24(12), 3481–3496 (2015).
  Medline CASGoogle Scholar
• 124. Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet 397(10276), 839–852 (2021).
  Medline CASGoogle Scholar
• 125. Wilson MR, Reske JJ, Holladay J et al. ARID1A mutations promote P300-dependent endometrial invasion through super-enhancer hyperacetylation. Cell Rep. 33(6), 108366 (2020).
  Medline CASGoogle Scholar
• 126. Shpargel KB, Mangini CL, Xie G, Ge K, Magnuson T. The KMT2D Kabuki syndrome histone methylase controls neural crest cell differentiation and facial morphology. Development 147(21), dev187997 (2020).
  Medline CASGoogle Scholar
• 127. Froimchuk E, Jang Y, Ge K. Histone H3 lysine 4 methyltransferase KMT2D. Gene. 627, 337–342 (2017).
  Medline CASGoogle Scholar
• 128. Fasciani A, D'Annunzio S, Poli V et al. MLL4-associated condensates counterbalance Polycomb-mediated nuclear mechanical stress in Kabuki syndrome. Nat. Genet. 52(12), 1397–1411 (2020).
  Medline CASGoogle Scholar
• 129. Mansour MR, Abraham BJ, Anders L et al. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element. Science 346(6215), 1373–1377 (2014).
  Medline CASGoogle Scholar
• 130. Wang K, Diskin SJ, Zhang H et al. Integrative genomics identifies LMO1 as a neuroblastoma oncogene. Nature 469(7329), 216–220 (2011).
  Medline CASGoogle Scholar
• 131. Oldridge DA, Wood AC, Weichert-Leahey N et al. Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism. Nature 528(7582), 418–421 (2015).
  Medline CASGoogle Scholar
• 132. Boeva V, Louis-Brennetot C, Peltier A et al. Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries. Nat. Genet. 49(9), 1408–1413 (2017).
  Medline CASGoogle Scholar
• 133. van Groningen T, Koster J, Valentijn LJ et al. Neuroblastoma is composed of two super-enhancer-associated differentiation states. Nat. Genet. 49(8), 1261–1266 (2017).
  Medline CASGoogle Scholar
• 134. Sawai CM, Sisirak V, Ghosh HS et al. Transcription factor Runx2 controls the development and migration of plasmacytoid dendritic cells. J. Exp. Med. 210(11), 2151–2159 (2013).
  Medline CASGoogle Scholar
• 135. Khan F, Hashmi F, Ghahramanyan N et al. Diagnosing and Treating Blastic Plasmacytoid Dendritic Cell Neoplasm in a Resource-Limited Setting. Oncology (Williston Park). 38(3), 104–106 (2024).
  MedlineGoogle Scholar
• 136. Kubota S, Tokunaga K, Umezu T et al. Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm. Nat. Commun. 10(1), 1653 (2019).
  MedlineGoogle Scholar
• 137. Wang P-S, Liu Z, Sweef O et al. Hexavalent chromium exposure activates the non-canonical nuclear factor kappa B pathway to promote immune checkpoint protein programmed death-ligand 1 expression and lung carcinogenesis. Cancer Lett. 589, 216827 (2024).
  MedlineGoogle Scholar
• 138. Alam H, Tang M, Maitituoheti M et al. KMT2D deficiency impairs super-enhancers to confer a glycolytic vulnerability in lung cancer. Cancer Cell 37(4), 599–617.e7 (2020).
  Medline CASGoogle Scholar
• 139. Herbert J, Coffin J. Reducing patient risk for human papillomavirus infection and cervical cancer. J. Am. Osteopath. Assoc. 108(2), 65–70 (2008).
  MedlineGoogle Scholar
• 140. Warburton A, Redmond CJ, Dooley KE et al. HPV integration hijacks and multimerizes a cellular enhancer to generate a viral-cellular super-enhancer that drives high viral oncogene expression. PLOS Genet. 14(1), e1007179 (2018).
  MedlineGoogle Scholar
• 141. Dooley KE, Warburton A, McBride AA. Tandemly integrated HPV16 can form a Brd4-dependent super-enhancer-like element that drives transcription of viral oncogenes. mBio 7(5), e01446–16 (2016).
  Medline CASGoogle Scholar
• 142. Hazawa M, Ikliptikawati DK, Iwashima Y et al. Super-enhancer trapping by the nuclear pore via intrinsically disordered regions of proteins in squamous cell carcinoma cells. Cell Chem. Biol. S2451-9456(23)00366–5 (2023).
  MedlineGoogle Scholar
• 143. Ahn JH, Davis ES, Daugird TA et al. Phase separation drives aberrant chromatin looping and cancer development. Nature 595(7868), 591–595 (2021).
  Medline CASGoogle Scholar
• 144. Bejaoui Y, Alresheq S, Durand S et al. DNA methylation profiling in Trisomy 21 females with and without breast cancer. Front Oncol. 13, 1203483 (2023).
  Medline CASGoogle Scholar
• 145. Deng R, Huang J-H, Wang Y et al. Disruption of super-enhancer-driven tumor suppressor gene RCAN1.4 expression promotes the malignancy of breast carcinoma. Mol. Cancer 19(1), 122 (2020).
  Medline CASGoogle Scholar
• 146. Shorstova T, Foulkes WD, Witcher M. Achieving clinical success with BET inhibitors as anti-cancer agents. Br. J. Cancer 124(9), 1478–1490 (2021).
  Medline CASGoogle Scholar